EDENRED : Oddo BHF lowers its price target
Its positive fundamental view of the stock remains unchanged, however, underpinned by high growth prospects, still significant margin improvement potential and strong free cash flow generation at €900 million per annum.
Oddo BHF also notes that Edenred's valuation has corrected very sharply since October 2023, and at 15 times PE 2025, suggests a 40% discount to its average over the last eight years and a 20% premium to Pluxee, which 'seems reasonable'.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as decision-making aids for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.
Go to the original article.
Contact us to request a correction